Funding for this research was provided by:
H. Lundbeck A/S
Received: 21 September 2021
Accepted: 15 November 2021
First Online: 25 November 2021
: Each study included in this analysis was approved by an institutional review board or independent ethics committee. The studies were registered at ExternalRef removed under ExternalRef removed, ExternalRef removed, ExternalRef removed, and ExternalRef removed. In each study, patients provided written informed consent to participate.
: Not applicable.
: <b>TRS</b> has been a consultant and/or scientific advisor for Alder/Lundbeck, Amgen, Biohaven, Eli Lilly, Impel Neuropharma, and Theranica, and has received research support from Alder/Lundbeck, Allergan, Amgen, Biohaven, Charleston Labs, Eli Lilly, electroCore, Novartis, Novo Nordisk, Satsuma, Theranica, and Vorso.<b>ELHS</b> received research grants as a clinical trial investigator from Alder BioPharmaceuticals and is also a member of Lundbeck’s Speaker Bureau.<b>RC, AE,</b> and <b>VS</b> are employees of Lundbeck or one of its subsidiary companies.<b>JH</b> is an employee of Pacific Northwest Statistical Consulting, Inc., a contracted service provider of biostatistical resources for H. Lundbeck A/S.